Attached files
| file | filename |
|---|---|
| EX-23 - EXHIBIT 23 - WEST PHARMACEUTICAL SERVICES INC | ex23consent_2014.htm |
| EX-24 - EXHIBIT 24 - WEST PHARMACEUTICAL SERVICES INC | ex24powersofattorney_2014.htm |
| EX-12.1 - EXHIBIT 12.1 - WEST PHARMACEUTICAL SERVICES INC | ex121ratioofearnings_2014.htm |
| EX-32.2 - EXHIBIT 32.2 - WEST PHARMACEUTICAL SERVICES INC | ex322cfo906certification_2.htm |
| EX-31.1 - EXHIBIT 31.1 - WEST PHARMACEUTICAL SERVICES INC | ex311ceo302certification_2.htm |
| EX-31.2 - EXHIBIT 31.2 - WEST PHARMACEUTICAL SERVICES INC | ex312cfo302certification_2.htm |
| EX-21 - EXHIBIT 21 - WEST PHARMACEUTICAL SERVICES INC | ex21listofsubsidiaries_2014.htm |
| EXCEL - IDEA: XBRL DOCUMENT - WEST PHARMACEUTICAL SERVICES INC | Financial_Report.xls |
| 10-K - 10-K - WEST PHARMACEUTICAL SERVICES INC | wst10k123114.htm |
| EX-10.15 - EXHIBIT 10.15 - WEST PHARMACEUTICAL SERVICES INC | ex1015separationagreement.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of West Pharmaceutical Services, Inc. (the “Company”) for the period ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Donald E. Morel, Jr., Ph.D., Chairman of the Board and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Donald E. Morel, Jr., Ph.D.
Donald E. Morel, Jr., Ph.D.
Chairman of the Board and Chief Executive Officer
Date: February 25, 2015